EGFR and neoplasm: Considering the role of CTLA-4 in potentiating immune responses against cancer cells, and the new evidences suggesting the role of EGFR not only in the survival of tumor cells but also in the inhibition of immune system [27], we investigated the effects of the immunoconjugate also on the immune cells.